In last trading session, ORIC Pharmaceuticals Inc (NASDAQ:ORIC) saw 0.61 million shares changing hands with its beta currently measuring 1.25. Company’s recent per share price level of $4.73 trading at -$0.01 or -0.21% at ring of the bell on the day assigns it a market valuation of $336.25M. That closing price of ORIC’s stock is at a discount of -210.15% from its 52-week high price of $14.67 and is indicating a premium of 17.55% from its 52-week low price of $3.90. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.59 million shares which gives us an average trading volume of 788.61K if we extend that period to 3-months.
For ORIC Pharmaceuticals Inc (ORIC), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.08. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
ORIC Pharmaceuticals Inc (NASDAQ:ORIC) trade information
Upright in the red during last session for losing -0.21%, in the last five days ORIC remained trading in the red while hitting it’s week-highest on Tuesday, 05/13/25 when the stock touched $4.73 price level, adding 14.77% to its value on the day. ORIC Pharmaceuticals Inc’s shares saw a change of -41.39% in year-to-date performance and have moved -6.89% in past 5-day. ORIC Pharmaceuticals Inc (NASDAQ:ORIC) showed a performance of 0.85% in past 30-days. Number of shares sold short was 11.19 million shares which calculate 13.46 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 12 to the stock, which implies a rise of 60.58% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 12. It follows that stock’s current price would drop -153.7% in reaching the projected high whereas dropping to the targeted low would mean a loss of -153.7% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -15.32% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -2.92% while estimates for its earnings growth in next 5 years are of 4.02%.
ORIC Pharmaceuticals Inc (NASDAQ:ORIC)’s Major holders
Insiders are in possession of 9.56% of company’s total shares while institution are holding 107.84 percent of that, with stock having share float percentage of 119.25%. Investors also watch the number of corporate investors in a company very closely, which is 107.84% institutions for ORIC Pharmaceuticals Inc that are currently holding shares of the company. NEXTECH INVEST LTD. is the top institutional holder at ORIC for having 5.29 million shares of worth $37.37 million. And as of 2024-06-30, it was holding 7.5136 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 4.92 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.9943 of outstanding shares, having a total worth of $34.79 million.
On the other hand, ACAP Strategic Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 1.92 shares of worth $9.08 million or 2.70% of the total outstanding shares. The later fund manager was in possession of 1.88 shares on Dec 31, 2024 , making its stake of worth around $8.91 million in the company or a holder of 2.65% of company’s stock.
